Details
Stereochemistry | RACEMIC |
Molecular Formula | C7H11NO2 |
Molecular Weight | 141.1677 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC1(C)CC(=O)NC1=O
InChI
InChIKey=HAPOVYFOVVWLRS-UHFFFAOYSA-N
InChI=1S/C7H11NO2/c1-3-7(2)4-5(9)8-6(7)10/h3-4H2,1-2H3,(H,8,9,10)
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000008486
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
||
|
NDF-RT |
N0000175753
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
05
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
||
|
LIVERTOX |
NBK547870
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
||
|
WHO-VATC |
QN03AD51
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
||
|
WHO-ATC |
N03AD01
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
||
|
WHO-ATC |
N03AD51
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
||
|
CFR |
21 CFR 862.3380
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
||
|
WHO-VATC |
QN03AD01
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
||
|
NCI_THESAURUS |
C264
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID7023019
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
PRIMARY | |||
|
m5071
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
PRIMARY | Merck Index | ||
|
1077
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
PRIMARY | |||
|
77-67-8
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
PRIMARY | |||
|
CHEMBL696
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
PRIMARY | |||
|
7182
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
PRIMARY | |||
|
C47523
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
PRIMARY | |||
|
5SEH9X1D1D
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
PRIMARY | |||
|
SUB07282MIG
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
PRIMARY | |||
|
ETHOSUXIMIDE
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
PRIMARY | |||
|
D005013
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
PRIMARY | |||
|
4887
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
PRIMARY | |||
|
201-048-7
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
PRIMARY | |||
|
Ethosuximide
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
PRIMARY | |||
|
5SEH9X1D1D
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
PRIMARY | |||
|
DB00593
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
PRIMARY | |||
|
4135
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
PRIMARY | RxNorm | ||
|
3291
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
PRIMARY | |||
|
1264002
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
PRIMARY | |||
|
1087
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
PRIMARY | |||
|
100000092816
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
PRIMARY | |||
|
64013
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
PRIMARY | |||
|
ETHOSUXIMIDE
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
PRIMARY | Description: A white or almost white powder or waxy solid; odourless or with a faint characteristic odour.Solubility: Freely soluble in water; very soluble in ethanol (~750 g/l) TS and ether R.Category: Anticonvulsant.Storage: Ethosuximide should be kept in a tightly closed container, protected from light.Additional information: Even in the absence of light, Ethosuximide is gradually degraded on exposure to a humid atmosphere, the decomposition being faster at higher temperatures.Definition: Ethosuximide contains not less than 99.0% and not more than 100.5% of C7H11NO2, calculated with reference to the anhydrous substance. | ||
|
1119
Created by
admin on Fri Dec 15 17:13:18 UTC 2023 , Edited by admin on Fri Dec 15 17:13:18 UTC 2023
|
PRIMARY |
ACTIVE MOIETY